9,10-dimethyl-1,2-benzanthracene and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one

9,10-dimethyl-1,2-benzanthracene has been researched along with 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cai, H; Hua, Z; Huang, H; Shi, J; Wei, Y; Zhang, L	1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one

Article	Year
Oroxylin A inhibits carcinogen-induced skin tumorigenesis through inhibition of inflammation by regulating SHCBP1 in mice. International immunopharmacology, 2020, Volume: 80 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carcinogens; Cell Line; Cytokines; Female; Flavonoids; Mice, Inbred ICR; RNA, Small Interfering; Shc Signaling Adaptor Proteins; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factor RelA	2020

Article

Year

Oroxylin A inhibits carcinogen-induced skin tumorigenesis through inhibition of inflammation by regulating SHCBP1 in mice.

International immunopharmacology, 2020, Volume: 80

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carcinogens; Cell Line; Cytokines; Female; Flavonoids; Mice, Inbred ICR; RNA, Small Interfering; Shc Signaling Adaptor Proteins; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factor RelA

2020